NO985824L - Forbedret fremgangsmÕte for fremstilling av kaliumklavulanat - Google Patents

Forbedret fremgangsmÕte for fremstilling av kaliumklavulanat

Info

Publication number
NO985824L
NO985824L NO985824A NO985824A NO985824L NO 985824 L NO985824 L NO 985824L NO 985824 A NO985824 A NO 985824A NO 985824 A NO985824 A NO 985824A NO 985824 L NO985824 L NO 985824L
Authority
NO
Norway
Prior art keywords
preparation
improved process
potassium clavulanate
clavulanate
potassium
Prior art date
Application number
NO985824A
Other languages
English (en)
Other versions
NO985824D0 (no
Inventor
Paul Gerard Butterly
John Gilroy Keohane
Esin Fatma Kosal
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO985824D0 publication Critical patent/NO985824D0/no
Publication of NO985824L publication Critical patent/NO985824L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
NO985824A 1996-06-13 1998-12-11 Forbedret fremgangsmÕte for fremstilling av kaliumklavulanat NO985824L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2048096P 1996-06-13 1996-06-13
PCT/US1997/010317 WO1997047301A1 (en) 1996-06-13 1997-06-13 Improved process for preparing potassium clavulanate

Publications (2)

Publication Number Publication Date
NO985824D0 NO985824D0 (no) 1998-12-11
NO985824L true NO985824L (no) 1999-02-10

Family

ID=21798851

Family Applications (1)

Application Number Title Priority Date Filing Date
NO985824A NO985824L (no) 1996-06-13 1998-12-11 Forbedret fremgangsmÕte for fremstilling av kaliumklavulanat

Country Status (18)

Country Link
US (1) US6414142B1 (no)
EP (1) EP0918520A4 (no)
JP (1) JP2000512297A (no)
KR (1) KR20000016544A (no)
CN (1) CN1115147C (no)
AR (1) AR008605A1 (no)
AU (1) AU712904B2 (no)
BR (1) BR9711803A (no)
CO (1) CO4970806A1 (no)
CZ (1) CZ407298A3 (no)
IL (1) IL127415A (no)
NO (1) NO985824L (no)
NZ (1) NZ333177A (no)
PL (1) PL186484B1 (no)
TR (1) TR199802452T2 (no)
TW (1) TW477700B (no)
WO (1) WO1997047301A1 (no)
ZA (1) ZA975198B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT400033B (de) 1992-03-10 1995-09-25 Biochemie Gmbh Neues verfahren zur isolierung und reinigung von clavulansäure und zur herstellung von pharmakologisch verträglichen salzen derselben
AT403375B (de) * 1995-11-15 1998-01-26 Biochemie Gmbh Verfahren zur fällung von alkalisalzen der clavulansäure
AU1234999A (en) * 1997-11-10 1999-05-31 Gist-Brocades B.V. Crystallization of beta-lactam compounds
ES2215628T5 (es) * 1999-04-01 2011-11-28 Dsm Ip Assets B.V. Aglomerados obtenidos por cristalización.
WO2008011136A2 (en) * 2006-07-20 2008-01-24 Sicor Inc. Process for the preparation of solid sterile active pharmaceutical ingredient
EP2575811B1 (en) 2010-06-03 2020-08-12 Mahmut Bilgic Pharmaceutical formulation comprising cefpodoxime proxetil and clavulanic acid

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1508977A (en) * 1974-04-20 1978-04-26 Beecham Group Ltd Beta-lactam antibiotic from streptomyces clavuligerus
GB1543563A (en) * 1975-02-07 1979-04-04 Glaxo Lab Ltd Beta-lactam antibiotic in purified form
DE3063683D1 (en) 1979-08-24 1983-07-14 Beecham Group Plc Amine salt of clavulanic acid, its preparation and use
US4454069A (en) * 1979-08-24 1984-06-12 Beecham Group Limited Clavulanic acid salts and their preparation from the tertiary butyl amine salt
CA1326486C (en) 1987-01-29 1994-01-25 Dennis Edward Clark Potassium clavulanate
US5288861A (en) * 1987-01-29 1994-02-22 Beecham Group Plc Potassium clavulanate in rosette form
AT399155B (de) * 1992-03-26 1995-03-27 Lek Tovarna Farmacevtskih Neue alkylendiammonium-diclavulanat-derivate, verfahren zu deren herstellung sowie deren verwendung
SI9300296B (sl) 1992-06-11 1998-06-30 Smithkline Beecham P.L.C. Postopek in intermedianti za pripravo klavulanske kisline
GB9305565D0 (en) 1993-03-18 1993-05-05 Smithkline Beecham Plc Novel compounds and processes
US5821364A (en) * 1993-03-26 1998-10-13 Gist-Brocades N.V. Diamine salts of clavulanic acid
JPH06298779A (ja) 1993-04-15 1994-10-25 Hoechst Japan Ltd ヘテロ環イミノビスメチレンビスホスホン酸誘導体
GB9401969D0 (en) 1994-02-02 1994-03-30 Smithkline Beecham Plc Process
SI9400107A (en) * 1994-03-02 1995-10-31 Lek Tovarna Farmacevtskih New process of the isolation of clavulanic acid and its pharmaceutical salts from fermented broth of streptomyces sp.p 6621 ferm p 2804.
TR199700828T1 (xx) * 1995-02-25 1998-04-21 Spurcourt Limited .Klavulanik asit tuzlar�.
GB9515809D0 (en) 1995-08-02 1995-10-04 Smithkline Beecham Plc Process

Also Published As

Publication number Publication date
PL330639A1 (en) 1999-05-24
WO1997047301A1 (en) 1997-12-18
BR9711803A (pt) 1999-08-24
AU3392797A (en) 1998-01-07
EP0918520A4 (en) 2000-01-12
ZA975198B (en) 1997-12-15
JP2000512297A (ja) 2000-09-19
TW477700B (en) 2002-03-01
PL186484B1 (pl) 2004-01-30
AR008605A1 (es) 2000-02-09
TR199802452T2 (xx) 1999-02-22
US6414142B1 (en) 2002-07-02
CN1115147C (zh) 2003-07-23
AU712904B2 (en) 1999-11-18
IL127415A (en) 2003-10-31
KR20000016544A (ko) 2000-03-25
CO4970806A1 (es) 2000-11-07
NO985824D0 (no) 1998-12-11
EP0918520A1 (en) 1999-06-02
CN1227488A (zh) 1999-09-01
NZ333177A (en) 2000-05-26
IL127415A0 (en) 1999-10-28
CZ407298A3 (cs) 1999-05-12

Similar Documents

Publication Publication Date Title
NO983766D0 (no) FremgangsmÕte til fremstilling av N-acetyl-D-glukosamin
NO992375L (no) FremgangsmÕte for fremstilling av benzylethere
NO970212L (no) Fremgangsmåte for fremstilling av enantiomerene av O-demetyltramadol
NO982237L (no) FremgangsmÕte for fremstilling av fenylimidazolidinderivater
NO20002174D0 (no) FremgangsmÕte for fremstilling av tiazolidindion-derivater
NO20023937L (no) Fremgangsmåte for fremstilling av substituert tiazolidindion
NO985824D0 (no) Forbedret fremgangsmÕte for fremstilling av kalium-clavulanat
NO996432L (no) Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider
NO984905L (no) FremgangsmÕte for fremstilling av b°rstevarer
NO985535L (no) FremgangsmÕte for fremstilling av 1,3-alkandioler
NO304110B1 (no) FremgangsmÕte for fremstilling av glutardialdehyd
NO941056L (no) Fremgangsmåte for fremstilling av organoklorsilaner
NO963432D0 (no) Fremgangsmåte for fremstilling av dimetyldiklorsilan
NO980316D0 (no) Fremgangsmåte for fremstilling av polymerisater av N-vinylkarprolaktam
NO972682D0 (no) Ny fremgangsmåte for fremstilling av sameridin
NO20003077D0 (no) FremgangsmÕte for fremstilling av klorbenzooksazolen
NO994793L (no) Fremgangsmåte for fremstilling av clavulansyre
NO972129D0 (no) Fremgangsmåte for fremstilling av 1-halo-3-trialkylsilanyl-benzenderivater
NO994557D0 (no) Fremgangsmaate for fremstilling av arylaminotriazolopyridiner
NO20002476L (no) FremgangsmÕte for fremstilling av formylimidazoler
NO942381L (no) Fremgangsmåte for fremstilling av indoler
NO961577L (no) Fremgangsmåte for fremstilling av tre-polymer-kompositter
NO964519D0 (no) Fremgangsmåte for fremstilling av chitosanalkylderivater
NO982975D0 (no) FremgangsmÕte for fremstilling av fosfatbundne keramer
NO972291D0 (no) Fremgangsmåte for fremstilling av optisk aktive forbindelser

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application